Frontier Biotechnologies Inc
SSE:688221
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Frontier Biotechnologies Inc's stock price target?
Not Available
Frontier Biotechnologies Inc doesn't have any price targets made by Wall Street professionals.
What is Frontier Biotechnologies Inc's Revenue forecast?
Projected CAGR
22%
For the last 6 years the compound annual growth rate for Frontier Biotechnologies Inc's revenue is 102%. The projected CAGR for the next 2 years is 22%.